Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

September 20, 2018

Older Stem Cell Transplant Patients with Non-Hodgkin’s Lymphoma at Higher Risk of Death, Study Suggests

News

Stem cell transplant to treat non-Hodgkin’s lymphoma in patients older than 65 is as effective as it is in younger patients, but is associated with a higher risk of non-relapse ... Read more

September 7, 2018

Common Therapy for Rare Blood Cancer May Activate ‘Dormant’ Lymphoma, Study Suggests

News

Treatment of myelofibrosis, a rare type of blood cancer, with Jakafi (ruxolitinib) gives a patient 16 times the risk of developing aggressive B-cell lymphoma, through the activation of a pre-existing ... Read more

August 8, 2018

Gazyva-Revlimid Combo Shows Promise for Follicular Lymphoma Patients in Clinical Trial

News

Gazyva (obinutuzumab) with Revlimid (lenalidomide) — a combination called Galen — is a potentially safe and effective treatment for relapsed or refractory follicular lymphoma, with over 60% of patients responding to treatment, ... Read more

August 6, 2018August 7, 2018

Compound Puts Cancer Cells into ‘Permanent Sleep’ in Mouse Study

News

Researchers in Australia have developed a new compound that arrests the growth and spread of cancer cells — including lymphoma — in mice, without the harmful side effects of conventional therapies. ... Read more

July 31, 2018

Dietary Supplement with Probiotics, Digestive Enzymes May Protect Gut from Chemotherapy Side Effects

News

Taking a dietary supplement with probiotics and digestive enzymes helped prevent damage to the gut’s microbial community from chemotherapy, a recent study suggests. The study, “Protection from chemotherapy- and antibiotic-mediated ... Read more

May 30, 2018

Atara’s Tab-cel Shows Promise for Treating Transplant-derived Lymphoma, Trial Data Shows

News

Atara Biotherapeutics’s investigative therapy Tab-cel (tabelecleucel) is a potentially safe and viable option to treat transplant-derived lymphoma, according to long-term data from two Phase 2 clinical trials. The new results will ... Read more

March 27, 2018

Venclexta-Rituxan Combo Reduced Disease Progression in Relapsed CLL Patients in Phase 3 Trial

News

A combination of Venclexta (venetoclax) and Rituxan (rituximab) significantly reduces the risk of disease progression or death in relapsed or refractory chronic lymphocytic leukemia (CLL) patients, according to a Phase 3 clinical ... Read more

March 2, 2018March 2, 2018

Researchers Discover a Non-invasive and Safe Way to Assess Stem Cell Transplants Earlier

News

An imaging agent called 18F-fluorothymidine (18F-FLT) allows researchers to assess how a patient is recovering after receiving a stem cell transplant earlier than current methods, according to a pilot study. ... Read more

February 19, 2018February 19, 2018

Interactive Online Program with Rewards Helps Kids Stay Active After Cancer Treatment, Study Shows

News

An online interactive system that offered rewards for exercising helped childhood cancer survivors stay physically active, according to results of a pilot clinical trial. Greater physical activity appeared to benefit their ... Read more

February 16, 2018February 16, 2018

Many Young Cancer Survivors Are Not Seeking Follow-up Care After Treatment, Study Finds

News

Many adolescent and young adult cancer survivors do not continue to receive follow-up care to reduce their long-term risks after ending treatment, according to a new study. This suggests that ... Read more